IP Library › Assignment 012243/0012
Patent Assignment
Reel/Frame 012243/0012

Assignment of Assignor's Interest

Recorded: 2001-12-17 Pages: 5
Assignor
CALYDON, INC
Executed: 2001-11-05
Assignee
CELL GENESYS, INC
IP DEPARTMENT, 342 LAKESIDE DRIVE, FOSTER CITY, CALIFORNIA, 94404
Covered Properties (29)
Tissue-Specific Enhancer Active in Prostate
Patent: 5,830,686 →
Application: 08/182,247 →
Tissue-Specific Enhancer Active in Prostate
Patent: 5,648,478 →
Application: 08/380,916 →
Tissue Specific Viral Vectors
Patent: 5,698,443 →
Application: 08/495,034 →
Tissue Specific and Tumor Growth Supperssion by Adenovirus Comprising Prostate Specific Antigen
Patent: 5,871,726 →
Application: 08/669,753 →
Prostate Cancer Drug Screening
Patent: 5,783,435 →
Application: 08/692,759 →
Tissue-Specific Enhancer Active in Prostate
Patent: 6,057,299 →
Application: 08/721,690 →
Prostate Cancer Drug Screening Using HKLK2 Enhancer
Patent: 6,051,417 →
Application: 08/906,192 →
Prostate Cancer Drug Screening
Application: 09/022,732 →
Adenovirus Vectors Specific for Cells Expressing Androgen Receptor and Methods of Use Thereof
Patent: 6,197,293 →
Application: 09/033,333 →
Adenovirus Vectors Specific for Cells Expressing Alpha-Fetoprotein and Methods of Use Thereof
Patent: 6,254,862 →
Application: 09/033,428 →
Adenovirus Vectors Specific for Cells Expressing Carcinoembryonic Antigen and Methods of Use Thereof
Application: 09/033,555 →
Adenovirus Vectors Containing Heterologous Transcription Regulatory Elements and Methods of Using Same
Patent: 6,432,700 →
Application: 09/033,556 →
Phospholipid Derivatives of Phosphono-Carboxylic Acids, the Production of Said Derivatives and the Use of Said Derivatives as Antiviral Medicaments
Patent: 6,136,797 →
Application: 09/077,891 →
Human Glandular Kallikrein Enhancer, Vectors Comprising the Enhancer and Methods of Use Thereof
Application: 09/127,834 →
Tissue Specific Adenoviral Vectors
Patent: 6,676,935 →
Application: 09/151,376 →
Publication: US 2003/0044383
Adenovirus Vectors Containing Cell Status-Specific Response Elements and Methods of Use Thereof
Patent: 6,900,049 →
Application: 09/392,822 →
Publication: US 2001/0053352
Methods of Enhancing Effectiveness of Therapeutic Viral Immunogenic Agent Administration
Patent: 6,406,861 →
Application: 09/413,044 →
Tissue-Specific Enhancer Active in Prostate
Application: 09/448,321 →
Target Cell-Specific Adenoviral Vectors Containing E3 and Methods of Use Thereof
Patent: 6,495,130 →
Application: 09/474,699 →
Adenovirus Vectors Specific for Cells Expressing Alpha-Fetoprotein and Methods of Use Thereof
Patent: 7,011,976 →
Application: 09/509,591 →
Adenovirus Vectors Specific for Cells Expressing Androgen Receptor and Methods of Use Thereof
Patent: 6,436,394 →
Application: 09/614,495 →
Tissue specific adenoviral vectors
Application: 09/732,169 →
Publication: US 2002/0068049
Human and Mouse Uroplakin Gene Transcriptional Regulatory Elements
Patent: 6,852,528 →
Application: 09/814,292 →
Publication: US 2002/0120117
Cell-Specific Adenovirus Vectors Comprising an Internal Ribosome Entry Site
Patent: 6,692,736 →
Application: 09/814,351 →
Publication: US 2003/0148520
Methods of Treating Neoplasia with Combination of Target-Cell Specific Adenovirus, Chemotherapy and Radiation
Patent: 6,911,200 →
Application: 09/814,357 →
Publication: US 2003/0068307
Tissue-specific enhancer active in prostate
Application: 09/861,682 →
Publication: US 2002/0198164
Human Glandular Kallikrein Enhancer, Vectors Comprising the Enhancer and Methods of Use Thereof
Patent: 6,916,918 →
Application: 09/875,228 →
Publication: US 2002/0136707
Rapid Methods and Kits for Detection and Semi-Quantitation of Anti-Adenovirus Antibody
Patent: 6,673,614 →
Application: 09/894,510 →
Publication: US 2002/0015947
Adenovirus Vectors Specific for Cells Expressing Alpha-Fetoprotein and Methods of Use Thereof
Patent: 6,585,968 →
Application: 09/898,883 →
Publication: US 2002/0164799
Related Assignments (23)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 16, 1996
From: HENDERSON, DANIEL ROBERT; SCHUUR, ERIC RODOLPH
To: CALYDON
Reel/Frame 008135/0877 →
Assignment of Assignor's Interest Oct 15, 1996
From: LAMPARSKI, HENRY G.; SCHUUR, ERIC RODOLPH; HENDERSON, DANIEL R.
To: CALYDON
Reel/Frame 008184/0119 →
Assignment of Assignor's Interest Sep 17, 1999
From: LITTLE, ANDREW S.; HENDERSON, DANIEL R.; SCHUUR, ERIC R.; LAMPARSKI, HENRY
To: CALYDON, INC.
Reel/Frame 010235/0455 →
Assignment of Assignor's Interest Dec 20, 1999
From: HENDERSON, DANIEL R.; YU, CHEN; YU, DE CHAO
To: CALYDON, INC.
Reel/Frame 010505/0226 →
Assignment of Assignor's Interest Jan 12, 2000
From: YU, DE CHAO; HENDERSON, DANIEL R.
To: CALYDON, INC.
Reel/Frame 010510/0232 →
Assignment of Assignor's Interest Feb 15, 2000
From: HENDERSON, DANIEL R.; SCHUUR, ERIC R.; LAMPARSKI, HENRY S.; YU, DE CHAO
To: CALYDON, INC.
Reel/Frame 010613/0797 →
Assignment of Assignor's Interest Apr 17, 2000
From: HENDERSON, DANIEL R.; YU, DE CHAO
To: CALYDON, INC.
Reel/Frame 010764/0417 →
Assignment of Assignor's Interest Dec 5, 2000
From: LITTLE, ANDREW S.; LAMPARSKI, HENRY G.; HENDERSON, DANIEL R.; SCHUUR, ERIC R.
To: CALYDON, INC.
Reel/Frame 011350/0643 →
Security Agreement Apr 10, 2001
From: CALYDON, INC.
To: PERSEUS CAPITAL, L.L.C.
Reel/Frame 011648/0035 →
Security Interest Jun 19, 2001
From: CALYDON, INC.
To: PERSEUS CAPTIAL, L.L.C.
Reel/Frame 011679/0302 →
Assignment of Assignor's Interest Oct 15, 2001
From: YU, DE-CHAO; ZHANG, HONG; HENDERSON, DANIEL R.
To: CALYDON, INC.
Reel/Frame 012268/0316 →
Assignment of Assignor's Interest Dec 26, 2001
From: YU, DE-CHAO; CHEN, YU; HENDERSON, DANIEL R.
To: CALYDON, INC.
Reel/Frame 012395/0761 →
Assignment of Assignor's Interest Jan 28, 2002
From: YU, DE-CHO; LI, YUANHAO; LITTLE, ANDREW S.; HENDERSON, DANIEL R.
To: CALYDON, INC.
Reel/Frame 012549/0232 →
Assignment of Assignor's Interest Jun 18, 2002
From: ROCHE DIAGNOSTICS GMBH
To: HEIDELBERG PHARMA HOLDING GMBH
Reel/Frame 013000/0237 →
Assignment of Assignor's Interest Feb 2, 2010
From: CELL GENESYS, INC.
To: BIOSANTE PHARMACEUTICALS, INC.
Reel/Frame 023973/0005 →
Assignment of Assignor's Interest Dec 10, 2010
From: BIOSANTE PHARMACEUTICALS, INC.
To: COLD GENESYS, INC.
Reel/Frame 025470/0885 →
Assignment of Assignor's Interest Dec 22, 2010
From: CELL GENESYS, INC.
To: BIOSANTE PHARMACEUTICALS, INC.
Reel/Frame 025561/0460 →
Assignment of Assignor's Interest Dec 22, 2010
From: BIOSANTE PHARMACEUTICALS, INC.
To: COLD GENESYS, INC.
Reel/Frame 025550/0722 →
Assignment of Assignor's Interest Dec 27, 2010
From: BIOSANTE PHARMACEUTICALS, INC.
To: COLD GENESYS, INC.
Reel/Frame 025537/0764 →
Assignment of Assignor's Interest Dec 27, 2010
From: BIOSANTE PHARMACEUTICALS, INC.
To: COLD GENESYS, INC.
Reel/Frame 025568/0888 →
Acceptance of Patent Rights Apr 26, 2011
From: BIOSANTE PHARMACEUTICALS, INC.
To: COLD GENESYS, INC.
Reel/Frame 026180/0885 →
Acceptance of Patent Rights Apr 26, 2011
From: BIOSANTE PHARMACEUTICALS, INC.
To: COLD GENESYS, INC.
Reel/Frame 026181/0163 →
Change of Name Nov 9, 2020
From: COLD GENESYS, INC.
To: CG ONCOLOGY, INC.
Reel/Frame 054362/0411 →